
‘Science is everything’
Olaposi Idowu Omotuyi has traveled the world for his education, and he believes in bringing the knowledge he’s gained back to his home country. His focus, for now, is on metabolic and infectious diseases with a special interest in developing plant-based antivirals.

Benin, Nigeria, and then studied pharmaceutical science in Japan before
returning to Nigeria to teach and do research.
Born in Ekiti State, Nigeria, Omotuyi was interested in science from a young age. One of his neighbors was a professor whose children were in training for medical lab science. They discussed their work with Omotuyi, kick-starting his fascination with how the world worked.
“In Africa, everything was voodoo until you understood what exactly what was going on,” he said. “That somebody could sit down and explain to me how the cells work, how tissues work, how organs interconnect into systems — that was fascinating.”
After completing his doctorate in biochemistry from the University of Benin, Nigeria, Omotuyi applied for a Japanese government Ministry of Education, Culture, Sports, Science and Technology scholarship in 2009. Through the program, scientists from all over the world conduct research in Japan. After several stages of interviews, Omotuyi was one of five applicants chosen for a position at Nagasaki University to work toward his second doctoral degree in pharmaceutical science.
In Japan, in a first-class laboratory and heavy scientific environment, he saw a sharp contrast between an industrialized country and Nigeria. He said he believes some African scientists might be tempted to stay in a country like Japan to do research, while others want to raise the level of science in Africa by returning to their home country. In the end, he chose to bring his skills back to Nigeria.

Fund, a tour of the Institute for Drug Research and Development at Afe Babalola
University.
The science was not the only thing that drew Omotuyi back. For him, being a tutor to undergraduate students first at Adekunle Ajasin University in Ondo State and now as a professor at the College of Pharmacy at Afe Babalola University, Ado-Ekiti, is “an absolute joy.”
“Not only being able to teach this experience, this knowledge to young people, but to be able to help them grow scientifically,” Omotuyi said. “I am really impressed at how they receive it.”
Few Nigerian scientists are able to translate their research into a product or policy that then is disseminated to a wide population in their country. Omotuyi said he has been fortunate in his networking and in the subject of his research to receive funding from the Afe Babalola University fund for translational research as well as garnering attention from other institutions for partnerships and funding. His lab now is studying both metabolic diseases and infectious diseases such as Ebola and COVID-19, which attracts government attention and resources.
An herbal drug called virudine developed in Omotuyi’s lab for the treatment of COVID-19 is undergoing independent investigation at the Nigerian Institute for Medical Research, and another repurposed drug for Lassa virus disease developed in partnership with the National Biotechnology Development Agency in Nigeria is being tested for proof-of-concept clinical trials by the NIMR.
Omotuyi teaches his students the importance of patriotism in their work. In countries like the United States, he sees that scientists apply research to their local environments and local problems, and these local solutions are accepted for international application. But African scientists end up doing research that benefits other countries instead of their own.
“African scientists who are exceptional at what they do are easily poachable,” Omotuyi said.
“The first point of science for me is that (my students) should solve local problems — and in solving them they should be innovative.”
Omotuyi said his favorite part of his work is getting to the biochemical details of how novel structures interact with macromolecules like proteins and nucleic acids, both during test tube experiments and in animal research models. But overall, the entire subject of biochemistry is what interests him.
“Science is something for me, like bread and drink, wake, sleep — everything,” he said. “Science, and nothing else.”

Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Castiglione and Ingolia win Keck Foundation grants
They will receive at least $1 million of funding to study the biological mechanisms that underly birds' longevity and sequence–function relationships of intrinsically disordered proteins.

How undergrad research catalyzes scientific careers
Undergraduate research doesn’t just teach lab skills, it transforms scientists. For Antonio Rivera and Julissa Cruz–Bautista, joining a lab became a turning point, fostering critical thinking, persistence and research identity.

Simcox and Gisriel receive mentoring award
They were honored for contributing their time, knowledge, energy and enthusiasm to mentoring postdocs in their labs.

ASBMB names 2025 Marion B. Sewer scholarship recipients
Ten undergraduates interested in biochemistry and molecular biology will each receive $2,000 toward their tuition and related educational costs.

Attie named honorary professor
This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.